Patents by Inventor Wentao WEI

Wentao WEI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12272527
    Abstract: A system and method suitable for removing both carbon-based contaminants and oxygen-based contaminants from a substrate within a single process chamber are disclosed.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: April 8, 2025
    Assignee: ASM IP Holding B.V.
    Inventors: Xing Lin, Chuang Wei, Wentao Wang, Peipei Gao, Fei Wang, Bubesh Babu Jotheeswaran
  • Publication number: 20250060651
    Abstract: A camera and an electronic apparatus are provided. The camera includes an image sensor and a lens assembly. The lens assembly is configured to form an image on the image sensor. The lens assembly includes multiple lens groups, and the multiple lens groups are arranged along an optical axis of the lens assembly. At least one of the multiple lens groups is movable relative to the image sensor to switch the lens assembly between a first mode and a second mode. A focusing object distance of the lens assembly in the first mode is less than a focusing object distance of the lens assembly in the second mode. The focusing object distance of the lens assembly in the first mode is less than 10 mm.
    Type: Application
    Filed: November 1, 2024
    Publication date: February 20, 2025
    Applicant: GUANGDONG OPPO MOBILE TELECOMMUNICATIONS CORP., LTD.
    Inventors: Jiawei CHEN, Yi WEI, Xiang LI, Pan YU, Wentao WANG
  • Patent number: 12099049
    Abstract: Provided are a method and device for recognizing hook effect in immune turbidimetry, and a computer readable medium. This method generates a reaction curve using light signals measured in a predetermined time period by immune reaction of analyte in a sample, and uses distribution information of the reaction curve in the predetermined time period to determine whether the sample has hook effect. This method only uses measurement information of a small predetermined time period in entire reaction time to determine whether a sample has hook effect, and terminates the test in time, thus accelerating the speed of immune turbidimetry detection of samples with hook effect.
    Type: Grant
    Filed: March 3, 2022
    Date of Patent: September 24, 2024
    Assignee: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    Inventors: Wenbo Zheng, Bo Ye, Wentao Wei
  • Publication number: 20240168554
    Abstract: An objective of the present disclosure is to provide a domain adaptation method and system for gesture recognition, which relates to the field of gesture recognition technologies. The domain adaptation method for gesture recognition includes: obtaining a to-be-recognized target domain surface electromyography signal of a user; separately inputting the to-be-recognized target domain surface electromyography signal into multiple target domain gesture recognition models, to obtain target domain gesture recognition results under multiple source-specific views, where source domains of training data used by different target domain gesture recognition models are different; and determining a gesture category of the to-be-recognized target domain surface electromyography signal according to the gesture recognition results under multiple source-specific views and a weight under each source-specific view.
    Type: Application
    Filed: November 21, 2023
    Publication date: May 23, 2024
    Applicant: Nanjing University of Science and Technology
    Inventors: Wentao WEI, Linyan REN, Bowen ZHOU
  • Patent number: 11382222
    Abstract: An LED display panel includes main frame made of a lightweight material, a supporting component and a control box. The main frame includes a first end surface for mounting a display screen and a second end surface opposing the first end surface. The supporting component includes a supporting tube and a plurality of supporting members. Fixing parts are arranged on peripheral edges of the second end surface, and the plurality of supporting members are correspondingly mounted on the fixing parts. A tube fixing part is arranged on an end of the supporting member far away from the second end surface, and the supporting tube is fixed on the tube fixing part. A power supply, a control system and a signal transmission system are arranged in the control box, and the control system and the signal transmission system are electrically connected to the power supply.
    Type: Grant
    Filed: November 13, 2019
    Date of Patent: July 5, 2022
    Assignee: SHENZHEN INFILED ELECTRONICS CO., LTD
    Inventors: Zongchao Hao, Qiuhe Liu, Wentao Wei
  • Publication number: 20220187278
    Abstract: Provided are a method and device for recognizing hook effect in immune turbidimetry, and a computer readable medium. This method generates a reaction curve using light signals measured in a predetermined time period by immune reaction of analyte in a sample, and uses distribution information of the reaction curve in the predetermined time period to determine whether the sample has hook effect. This method only uses measurement information of a small predetermined time period in entire reaction time to determine whether a sample has hook effect, and terminates the test in time, thus accelerating the speed of immune turbidimetry detection of samples with hook effect.
    Type: Application
    Filed: March 3, 2022
    Publication date: June 16, 2022
    Inventors: Wenbo ZHENG, Bo YE, Wentao WEI
  • Publication number: 20210378111
    Abstract: An LED display panel includes main frame made of a lightweight material, a supporting component and a control box. The main frame includes a first end surface for mounting a display screen and a second end surface opposing the first end surface. The supporting component includes a supporting tube and a plurality of supporting members. Fixing parts are arranged on peripheral edges of the second end surface, and the plurality of supporting members are correspondingly mounted on the fixing parts. A tube fixing part is arranged on an end of the supporting member far away from the second end surface, and the supporting tube is fixed on the tube fixing part. A power supply, a control system and a signal transmission system are arranged in the control box, and the control system and the signal transmission system are electrically connected to the power supply.
    Type: Application
    Filed: November 13, 2019
    Publication date: December 2, 2021
    Applicant: SHENZHEN INFILED ELECTRONICS CO., LTD
    Inventors: Zongchao HAO, Qiuhe LIU, Wentao WEI
  • Patent number: 10221231
    Abstract: The present invention relates to fusion proteins for the expression of G-protein coupled receptor proteins (GPCR) with the fusion partners, as inserted fragments, from mammalian cells. The fusion partners are from a fragment of APJ protein (“the APJ protein fragment”) or a fragment with homology of more than 90% similarity to the APJ protein fragment; or a fragment of RGS16 protein (the “RGS16 protein fragment”) or a fragment with homology of more than 90% similarity to the RGS16 protein fragment; or the fragment of DNJ protein (the “DNJ protein fragment”) or a fragment with homology of more than 90% similarity to DNJ protein fragment. The fusion expression of GPCR with the above mentioned fusion partners can improve the protein yield and stability when purified from cells. Therefore, these fusion protein partners can be widely used for the study of GPCR proteins.
    Type: Grant
    Filed: April 24, 2017
    Date of Patent: March 5, 2019
    Assignee: VIVA BIOTECH (SHANGHAI) LTD.
    Inventors: Jianhua Cai, Jian Shen, Fan Jiang, Na Li, Wentao Wei, Xiuhong Zeng, Xiaoyan Su, Min Han, Delin Ren, Chen Mao
  • Patent number: 10106595
    Abstract: The present invention relates to fusion proteins for the expression of G-protein coupled receptor proteins (GPCR) with the fusion partners, as inserted fragments, from mammalian cells. The fusion partners are from a fragment of APJ protein (“the APJ protein fragment”) or a fragment with homology of more than 90% similarity to the APJ protein fragment; or a fragment of RGS16 protein (the “RGS16 protein fragment”) or a fragment with homology of more than 90% similarity to the RGS16 protein fragment; or the fragment of DNJ protein (the “DNJ protein fragment”) or a fragment with homology of more than 90% similarity to DNJ protein fragment. The fusion expression of GPCR with the above mentioned fusion partners can improve the protein yield and stability when purified from cells. Therefore, these fusion protein partners can be widely used for the study of GPCR proteins.
    Type: Grant
    Filed: April 24, 2017
    Date of Patent: October 23, 2018
    Assignee: VIVA BIOTECH (SHANGHAI) LTD.
    Inventors: Jianhua Cai, Jian Shen, Fan Jiang, Na Li, Wentao Wei, Xiuhong Zeng, Xiaoyan Su, Min Han, Delin Ren, Chen Mao
  • Publication number: 20170226186
    Abstract: The present invention relates to fusion proteins for the expression of G-protein coupled receptor proteins (GPCR) with the fusion partners, as inserted fragments, from mammalian cells. The fusion partners are from a fragment of APJ protein (“the APJ protein fragment”) or a fragment with homology of more than 90% similarity to the APJ protein fragment; or a fragment of RGS16 protein (the “RGS16 protein fragment”) or a fragment with homology of more than 90% similarity to the RGS16 protein fragment; or the fragment of DNJ protein (the “DNJ protein fragment”) or a fragment with homology of more than 90% similarity to DNJ protein fragment. The fusion expression of GPCR with the above mentioned fusion partners can improve the protein yield and stability when purified from cells. Therefore, these fusion protein partners can be widely used for the study of GPCR proteins.
    Type: Application
    Filed: April 24, 2017
    Publication date: August 10, 2017
    Applicant: VIVA BIOTECH (SHANGHAI) LTD.
    Inventors: Jianhua Cai, Jian Shen, Fan Jiang, Na Li, Wentao Wei, Xiuhong Zeng, Xiaoyan Su, Min Han, Delin Ren, Chen Mao
  • Publication number: 20170226187
    Abstract: The present invention relates to fusion proteins for the expression of G-protein coupled receptor proteins (GPCR) with the fusion partners, as inserted fragments, from mammalian cells. The fusion partners are from a fragment of APJ protein (“the APJ protein fragment”) or a fragment with homology of more than 90% similarity to the APJ protein fragment; or a fragment of RGS16 protein (the “RGS16 protein fragment”) or a fragment with homology of more than 90% similarity to the RGS16 protein fragment; or the fragment of DNJ protein (the “DNJ protein fragment”) or a fragment with homology of more than 90% similarity to DNJ protein fragment. The fusion expression of GPCR with the above mentioned fusion partners can improve the protein yield and stability when purified from cells. Therefore, these fusion protein partners can be widely used for the study of GPCR proteins.
    Type: Application
    Filed: April 24, 2017
    Publication date: August 10, 2017
    Applicant: VIVA BIOTECH (SHANGHAI) LTD.
    Inventors: Jianhua Cai, Jian Shen, Fan Jiang, Na Li, Wentao Wei, Xiuhong Zeng, Xiaoyan Su, Min Han, Delin Ren, Chen Mao
  • Patent number: 9670252
    Abstract: The present invention relates to fusion proteins for the expression of G-protein coupled receptor proteins (GPCR) with the fusion partners, as inserted fragments, from mammalian cells. The fusion partners are from a fragment of APJ protein (“the APJ protein fragment”) or a fragment with homology of more than 90% similarity to the APJ protein fragment; or a fragment of RGS16 protein (the “RGS16 protein fragment”) or a fragment with homology of more than 90% similarity to the RGS16 protein fragment; or the fragment of DNJ protein (the “DNJ protein fragment”) or a fragment with homology of more than 90% similarity to DNJ protein fragment. The fusion expression of GPCR with the above mentioned fusion partners can improve the protein yield and stability when purified from cells. Therefore, these fusion protein partners can be widely used for the study of GPCR proteins.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: June 6, 2017
    Assignee: VIVA BIOTECH (SHANGHAI) LTD.
    Inventors: Jianhua Cai, Jian Shen, Fan Jiang, Na Li, Wentao Wei, Xiuhong Zeng, Xiaoyan Su, Min Han, Delin Ren, Chen Mao
  • Publication number: 20150166609
    Abstract: The present invention relates to fusion proteins for the expression of G-protein coupled receptor proteins (GPCR) with the fusion partners, as inserted fragments, from mammalian cells. The fusion partners are from a fragment of APJ protein (“the APJ protein fragment”) or a fragment with homology of more than 90% similarity to the APJ protein fragment; or a fragment of RGS16 protein (the “RGS16 protein fragment”) or a fragment with homology of more than 90% similarity to the RGS16 protein fragment; or the fragment of DNJ protein (the “DNJ protein fragment”) or a fragment with homology of more than 90% similarity to DNJ protein fragment. The fusion expression of GPCR with the above mentioned fusion partners can improve the protein yield and stability when purified from cells. Therefore, these fusion protein partners can be widely used for the study of GPCR proteins.
    Type: Application
    Filed: February 27, 2015
    Publication date: June 18, 2015
    Inventors: Jianhua CAI, Jian SHEN, Fan JIANG, Na LI, Wentao WEI, Xiuhong ZENG, Xiaoyan SU, Min HAN, Delin REN, Chen MAO